Cancer Research Institute Media Room
SURGE Therapeutics Raises $32M Series B Financing to Advance IntraoperativeImmunotherapy to Improve Cancer Patient Survival Outcomes Post-Surgery
For media inquiries, please contact us at [email protected]
Stay up to date
Join our email list for updates on cancer immunotherapy research, events, and opportunities to get involved with the Cancer Research Institute. Sign up below and be a force for change in the fight against cancer.
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.
